Showing results (351-360 of 554) with videos related to
Sort By:
Pageof 56
Nature Biomedical Engineering|September 7, 2023
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNABowen Li, Allen Yujie Jiang, Idris Raji, et al.Science Translational Medicine|September 6, 2023
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseasesJonathan D Herman, Caroline Atyeo, Yonatan Zur, et al.Cell|November 18, 2020
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityTomer Zohar, Carolin Loos, Stephanie Fischinger, et al.Plos Medicine|November 2, 2006
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1Marcus Altfeld, Elizabeth T Kalife, Ying Qi, et al.American Journal of Obstetrics and Gynecology|July 22, 2022
COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant womenCaroline Atyeo, Lydia L Shook, Nadege Nziza, et al.Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformXin Tong, Benjamin Kellman, Maria-Jose Avendano, et al.Journal of Virology|September 29, 2005
De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionTodd M Allen, Xu G Yu, Elizabeth T Kalife, et al.Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.Plos Biology|February 10, 2022
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohortEmilie Finch, Rachel Lowe, Stephanie Fischinger, et al.Pageof 56